Ahead of IPO, Manipal Health faces minority shareholders' complaints, but company denies allegations

Ahead of its anticipated IPO, Manipal Health is embroiled in a dispute with some of its minority shareholders. U.S.-based investors have raised allegations of fraud, dilution of shares, and unmet promises. These complaints have surfaced at a critical time, potentially complicating the company's public offering plans. The investors claim that Manipal Health has not been transparent about its financial dealings and accuse the company of actions that have adversely affected their share value. They argue that these alleged practices could mislead potential IPO investors. Despite the serious nature of these accusations, the company maintains that it has adhered to all legal requirements and operated with full transparency. In response, Manipal Health has firmly denied the allegations, citing prior audits and financial disclosures that supposedly refute the investors' claims. The company insists that it has consistently communicated with shareholders and fulfilled all its obligations. As the IPO approaches, Manipal Health remains focused on its growth trajectory, aiming to reassure stakeholders and the market of its robust financial health and governance.

— Authored by Next24 Live